Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L02BX03	ABREMIA	G	Abiraterone acetate - 250mg	250mg	Tablet	77,478,802 L.L
L02BX03	ABLAX 500	G	Abiraterone acetate - 500mg	500mg	Tablet	45,056,853 L.L
L02BX03	APO-ABIRATERONE	G	Abiraterone acetate - 500mg	500mg	Tablet, film coated	46,110,590 L.L
L02BX03	ABREMIA	G	Abiraterone acetate - 250mg	250mg	Tablet	L.L
L02BX03	ABLAX 250	G	Abiraterone acetate - 250mg	250mg	Tablet	L.L
L02BX03	ABLAX 500	G	Abiraterone acetate - 500mg	500mg	Tablet	L.L
L02BG04	APO-LETROZOLE	G	Letrozole - 2.5mg	2.5mg	Tablet	1,962,010 L.L
L02BG03	ARIMIDEX	B	Anastrozole - 1mg	1mg	Tablet, film coated	3,202,377 L.L
L02BG03	ANASTROZOL GP PHARM	G	Anastrozole - 1mg	1mg	Tablet, film coated	1,181,238 L.L
L02BG03	ANASTROZOLE ARROW LAB	G	Anastrozole - 1mg	1mg	Tablet	1,552,138 L.L
L02BG03	ANASTROZOLE BIOGARAN	G	Anastrozole - 1mg	1mg	Tablet, coated	3,800,387 L.L
L02BG03	APO-ANASTROZOLE	G	Anastrozole - 1mg	1mg	Tablet	2,615,118 L.L
L01XX35	ANAGRELIDE BIOGARAN	G	Anagrelide - 0.5mg	0.5mg	Capsule	15,754,068 L.L
L01XK52	AKEEGA	B	Niraparib - 100mg, Abiraterone acetate - 500mg		Tablet, film coated	519,366,124 L.L
L01XK52	AKEEGA	B	Niraparib - 50mg, Abiraterone acetate - 500mg		Tablet, film coated	519,366,124 L.L
L01XG01	ALVOCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	14,169,600 L.L
L01FX05	ADCETRIS	BioTech	Brentuximab Vedotin - 50mg	50mg	Injectable powder for concentrate for solution	L.L
L01FX05	ADCETRIS	BioTech	Brentuximab Vedotin - 50mg	50mg	Injectable powder for concentrate for solution	298,266,862 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrated solution	75,875,312 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 400mg	400mg	Injectable concentrated solution	75,875,312 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrated solution	24,533,456 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 100mg	100mg	Injectable concentrated solution	24,533,456 L.L
L01FD01	ARYOTRUST	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for concentrate for solution + solvent	34,948,930 L.L
L01FD01	ARYOTRUST	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for concentrate for solution	21,176,745 L.L
L01EG02	AFINITOR	B	Everolimus - 5mg	5mg	Tablet	149,280,650 L.L
L01EG02	AFINITOR	B	Everolimus - 10mg	10mg	Tablet	214,897,705 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 30mg	30mg	Tablet, film coated	124,685,776 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 90mg	90mg	Tablet, film coated	374,059,747 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 180mg	180mg	Tablet, film coated	493,595,998 L.L
L01ED03	ALECENSA	B	Alectinib - 150mg	150mg	Capsule, hard	490,837,809 L.L

...